Jabra Enhance Select 300 vs Otofonix Encore

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 among 65 OTC hearing aids tested, placing it in the top 25% of its category. In our testing, the Enhance Select 300 demonstrates notable strengths in speech clarity for quiet environments, scoring 0.85 points above the OTC category average. Feedback handling is excellent at 5.0/5, and own-voice comfort scores a solid 3.5/5—nearly a full point above average for the category. Music streaming performance, while above average for OTC devices, remains mixed in absolute terms at 2.6/5. The device's main limitation appears in challenging listening environments. Speech-in-noise performance scored 1.5/5, which is low in absolute terms and essentially matches the category average. Users who frequently encounter noisy restaurants, busy offices, or crowded gatherings may find this a meaningful constraint. The Enhance Select 300 is best suited for individuals who primarily need improved hearing in quieter settings such as home conversations, one-on-one meetings, or watching television. It offers reliable streaming to both iPhone and Android devices, rechargeable batteries, and hands-free functionality. Shoppers seeking stronger noise performance at this price point may want to compare alternatives like the Lucid Tala or Audicus Omni 2, which scored higher overall in our testing.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.